bluebird bio Statistics
Total Valuation
CV Sciences has a market cap or net worth of 7.32 million. The enterprise value is 7.53 million.
| Market Cap | 7.32M |
| Enterprise Value | 7.53M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CV Sciences has 184.26 million shares outstanding. The number of shares has increased by 15.44% in one year.
| Current Share Class | 184.26M |
| Shares Outstanding | 184.26M |
| Shares Change (YoY) | +15.44% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 8.62% |
| Owned by Institutions (%) | n/a |
| Float | 168.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 3.87 |
| P/TBV Ratio | 8.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.02 |
| EV / Sales | 0.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.62 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.14 |
| Quick Ratio | 0.24 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.13 |
| Interest Coverage | -1.50 |
Financial Efficiency
Return on equity (ROE) is -88.15% and return on invested capital (ROIC) is -12.22%.
| Return on Equity (ROE) | -88.15% |
| Return on Assets (ROA) | -4.18% |
| Return on Invested Capital (ROIC) | -12.22% |
| Return on Capital Employed (ROCE) | -21.64% |
| Revenue Per Employee | 318,938 |
| Profits Per Employee | -39,063 |
| Employee Count | 49 |
| Asset Turnover | 1.89 |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | -7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.77% in the last 52 weeks. The beta is 0.60, so CV Sciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -30.77% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 49.39 |
| Average Volume (20 Days) | 147,135 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, CV Sciences had revenue of 15.31 million and -1.88 million in losses. Loss per share was -0.01.
| Revenue | 15.31M |
| Gross Profit | 6.97M |
| Operating Income | -543,000 |
| Pretax Income | -1.88M |
| Net Income | -1.88M |
| EBITDA | -190,000 |
| EBIT | -543,000 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 812,000 in cash and 1.03 million in debt, giving a net cash position of -213,000 or -0.00 per share.
| Cash & Cash Equivalents | 812,000 |
| Total Debt | 1.03M |
| Net Cash | -213,000 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 1.89M |
| Book Value Per Share | 0.01 |
| Working Capital | 711,000 |
Cash Flow
In the last 12 months, operating cash flow was -424,000 and capital expenditures -58,000, giving a free cash flow of -482,000.
| Operating Cash Flow | -424,000 |
| Capital Expenditures | -58,000 |
| Free Cash Flow | -482,000 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 45.55%, with operating and profit margins of -3.55% and -12.25%.
| Gross Margin | 45.55% |
| Operating Margin | -3.55% |
| Pretax Margin | -12.29% |
| Profit Margin | -12.25% |
| EBITDA Margin | -1.24% |
| EBIT Margin | -3.55% |
| FCF Margin | n/a |
Dividends & Yields
CV Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.44% |
| Shareholder Yield | n/a |
| Earnings Yield | -25.63% |
| FCF Yield | -6.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CV Sciences has an Altman Z-Score of -13.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.02 |
| Piotroski F-Score | 3 |